Product Images Trintellix
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Trintellix NDC 55154-0257 by Cardinal Health 107, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
86c93382 d2e2 452e b198 3ed638f5faa0 00
This appears to be prescription drug packaging information, with some general warnings and manufacturer information. The drug is called Trintellix and it should be stored at 25°C. The package includes a medication guide and the drug was manufactured in Italy. The trademark is owned by H. Lundbeck A/S and used under license by Takeda Pharmaceuticals America, Inc. The package warns against accepting it if the seal over the bottle opening is broken or missing.*
86c93382 d2e2 452e b198 3ed638f5faa0 01
This appears to be the packaging information for a medication called Trintellix, manufactured by H. Lundbeck A/S and distributed by Takeda Pharmaceuticals America, Inc. The package has storage instructions, information on dosage, and a warning to not use if the seal is broken or missing. It also advises dispensing with the accompanying medication guide and provides the contact information for the distributor, Cardinal Health.*
Figure 1 - trintellix 01
Figure 2 - trintellix 02
Figure 3 - trintellix 03
This text appears to be a list of different drugs and their effects on certain enzymes in the body. It includes CYP2D6 inhibitors like Buproprion, CVP inducers like Rifampin, and CYP2CORCINA inhibitors like Fluconazole. The text also mentions Omeprazole as a CYP2C19 inhibitor and the presence of Ethanol. Overall, this appears to be information for medical professionals or researchers studying drug interactions and enzyme activity in the body.*
Chemical Structure - trintellix 04
This appears to be a list of drugs and their interactions with various enzymes. The drugs mentioned include bupropion, omeprazole, aspirin, and ethanol. The enzymes mentioned include CYP2B6, CYP2C19, and CYP3A. However, the text is not formatted clearly and some of the characters are not readable, so it is difficult to provide a more detailed or accurate description.*
Figure 4 - trintellix 05
Figure 5 - trintellix 06
Figure 6 - trintellix 07
This appears to be a table related to a study or clinical trial. The drug being evaluated is TRINTELLIX aka Sorfomg, and it is being compared to a placebo. The table shows the proportion of patients with recurrence over time in weeks. However, without the full context or explanation of the study, it is difficult to provide a more detailed description or interpretation.*
Figure 7 - trintellix 08
Figure 8 - trintellix 09
trintellix 10
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.